The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Sjögren's syndrome associated with systemic lupus erythematosus: Clinical and laboratory profiles and comparison with primary Sjögren's syndrome
Abstract
Objective.: To address the clinical, serologic, pathologic, and immunogenetic features of sicca syndrome that occurs in systemic lupus erythematosus (SLE), as well as its similarities to, and differences from, sicca syndrome that occurs in primary Sjögren's syndrome (SS). Methods.: A cohort of 283 consecutive unselected SLE patients was evaluated for the presence of associated SS using the American–European classification criteria. Clinical and laboratory parameters in SLE patients with SS (SLE–SS) were compared with those in SLE patients without SS (SLE–no SS) and with a group of 86 unselected patients with primary SS. Results.: SS was identified in 26 SLE patients (9.2%); the SS preceded the development of lupus in 18 of them (69.2%). Compared with the SLE–no SS group, patients with SLE–SS were significantly older, had a higher frequency of Raynaud's phenomenon, anti‐Ro/SSA, anti‐La/SSB, and rheumatoid factor, but had a significantly lower frequency of renal involvement, lymphadenopathy, and thrombocytopenia. Compared with the primary SS group, SLE–SS patients displayed a clinically similar sicca syndrome, but were significantly younger and had an increased frequency of perivascular infiltrates in the salivary glands associated with anticardiolipin antibodies in the serum. SLE–SS patients had a high frequency of the DRB1*0301 allele. This HLA profile distinguished the SLE–SS group from the SLE–no SS group, who had an increased frequency of DRB1*1501 and DQB1*0602 alleles, but was similar to the HLA profile of the primary SS group, who had an increased frequency of DRB1*0301. Conclusion.: SLE–SS appears to constitute a subgroup of patients with distinct clinical, serologic, pathologic, and immunogenetic features, in whom SS is expressed as an overlapping entity and is largely similar to primary SS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E., Fox, P. C., Fox, R. I., Kassan, S. S., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.554 · Cited by 5,299
Self-citationACR AD HOC COMMITTEE ON NEUROPSYCHIATRIC LUPUS NOMENCLATURE (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:4<599::aid-anr2>3.0.co;2-f · Cited by 2,202
Applied Multivariate Data Analysis
Jobson, J. D. (1992) · Springer Texts in Statistics · doi:10.1007/978-1-4612-0921-8 · Cited by 1,825
Labial salivary gland biopsy in Sjögren's disease
Chisholm, D. M., & Mason, D. K. (1968) · Journal of Clinical Pathology · doi:10.1136/jcp.21.5.656 · Cited by 1,017
Clinical evolution, and morbidity and mortalityof primary Sjögren's syndrome
Skopouli, F. N., Dafni, U., Ioannidis, J. P. A., & Moutsopoulos, H. M. (2000) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(00)80016-5 · Cited by 488
Self-citationVitali, C., Bombardieri, S., Moutsopoulos, H. M., Coll, J., Gerli, R., Hatron, P. Y., Kater, L., Konttinen, Y. T., Manthorpe, R., Meyer, O., et al. (1996) · Annals of the Rheumatic Diseases · doi:10.1136/ard.55.2.116 · Cited by 464
Self-citationHigh prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population.
Manoussakis, M. N., Tzioufas, A. G., Silis, M. P., Pange, P. J. E., Goudevenos, J. A., & Moutsopoulos, H. Μ. (1987) · PubMed · Cited by 339
Self-citationMoutsopoulos, H. M., Webber, B. L., Vlagopoulos, T. P., Chused, T. M., & Decker, J. L. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)91110-0 · Cited by 197
Self-citationSjogren's Syndrome and Systemic Lupus Erythematosus
Heaton, J. M. (1959) · BMJ · doi:10.1136/bmj.1.5120.466 · Cited by 141
Smith, E. L., & Shmerling, R. H. (1999) · Lupus · doi:10.1191/096120399680411317 · Cited by 124
Gilboe, I.-M., Kvien, T. K., Uhlig, T., & Husby, G. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.12.1103 · Cited by 122
Vlachoyiannopoulos, P. G., Karassa, F. B., Karakostas, K. X., Drosos, A. A., & Moutsopoulos, H. Μ. (1993) · Lupus · doi:10.1177/096120339300200505 · Cited by 103
Self-citationSjögren's Syndrome in Systemic Lupus Erythematosus: Clinical and Subclinical Manifestations
Alarcón-Segovia, D., IBÁÑEZ, G., VELÁZQUEZ-FORERO, F., HERNÁNDEZ-ORTÍZ, J., & GONZÁLEZ-JIMÉNEZ, Y. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-5-577 · Cited by 98
Advances in Internal Medicine.
(1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-1-148_4 · Cited by 84
Sjögren's syndrome in systemic lupus erythematosus.
Andonopoulos, A. P., Skopouli, F. N., Dimou, G. S., Drosos, A. A., & Moutsopoulos, H. Μ. (1990) · PubMed · Cited by 74
Self-citationSjögren's syndrome: current concepts.
Manoussakis, M. N., & Moutsopoulos, H. Μ. (2001) · PubMed · Cited by 46
Self-citationWilson (1999) · doi:10.1002/1529-0131(199907)42:7<1309::aid-anr1>3.0.co;2-f
Cited by
Fox, R. I. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66990-5 · Cited by 1,828
Brito-Zerón, P., Baldini, C., Bootsma, H., Bowman, S. J., Jonsson, R., Mariette, X., Sivils, K., Theander, E., Tzioufas, A., & Ramos-Casals, M. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.47 · Cited by 868
Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases
Shoenfeld, Y., Gerli, R., Doria, A., Matsuura, E., Cerinic, M. M., Ronda, N., Jara, L. J., Abu-Shakra, M., Meroni, P. L., & Sherer, Y. (2005) · Circulation · doi:10.1161/circulationaha.104.507996 · Cited by 555
The epidemiology of Sjögren’s syndrome
Shahane, A., & Patel, R. (2014) · Clinical Epidemiology · doi:10.2147/clep.s47399 · Cited by 354
Primary Sjögren's syndrome: new clinical and therapeutic concepts
Ramos-Casals, M., Tzioufas, A. G., & Font, J. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.025676 · Cited by 295
Metadata
- Authors
- Manoussakis, M. N., Georgopoulou, C., Zintzaras, E., Spyropoulou, M., Stavropoulou, A., Skopouli, F. N., & Moutsopoulos, H. M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2004-03
- Volume
- 50
- Issue
- 3
- Pages
- 882-891
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2069646839
- Cited by
- 255
- References
- 17
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.